Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001157523-08-002250
Filing Date
2008-03-17
Accepted
2008-03-14 21:59:44
Documents
7
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 ORE PHARMACEUTICALS INC. 10-K a5633704.htm 10-K 1590141
2 EXHIBIT 10.85A a5633704ex10-85a.htm EX-10.85A 181428
3 EXHIBIT 21.1 a5633704ex21_1.htm EX-21.1 1387
4 EXHIBIT 23.1 a5633704a23_1.htm EX-23.1 30374
5 EXHIBIT 31 a5633704ex31.htm EX-31 30074
6 EXHIBIT 32 a5633704ex32.htm EX-32 11739
7 GRAPH, PAGE 23 graph.jpg GRAPHIC 29774
  Complete submission text file 0001157523-08-002250.txt   1887711
Mailing Address 50 WEST WATKINS MILL ROAD GAITHERSBURG MD 20878
Business Address 50 WEST WATKINS MILL ROAD GAITHERSBURG MD 20878 3019871700
GENE LOGIC INC (Filer) CIK: 0001043914 (see all company filings)

EIN.: 061411336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23317 | Film No.: 08691057
SIC: 2835 In Vitro & In Vivo Diagnostic Substances